Skip to main content
ID Biomedical Corporation logo

ID Biomedical Corporation — Investor Relations & Filings

Ticker · IDBE ISIN · US44936D1081 LEI · 213800B6ED44TX9J9Z71 TSX Manufacturing
Filings indexed 1 across all filing types
Latest filing 2006-01-13 Regulatory Filings
Country CA Canada
Listing TSX IDBE

About ID Biomedical Corporation

https://www.gsk.com/en-gb/home/

ID Biomedical Corporation was a biotechnology company specializing in the research, development, manufacturing, and marketing of innovative vaccine products against infectious diseases. The company focused on developing subunit vaccines, including those targeting influenza (marketed products included Fluviral) and Group A streptococcus. ID Biomedical also marketed NeisVac-C for meningitis. Known for utilizing traditional egg-based production methods, the company manufactured seasonal flu vaccines for the global market from its facility in Quebec. Following its acquisition by GlaxoSmithKline (GSK) in 2005, its operations, particularly vaccine manufacturing and development capabilities, were integrated into GSK's infectious disease portfolio.

Recent filings

Filing Released Lang Actions
Other securityholders documents - English.pdf
Regulatory Filings
2006-01-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.